Caroline Relton

She moved to the University of Bristol in 2012. Relton investigates the variations in epidemiology that cause disease, and how these can be used to predict disease.^[4] She uses population-based approaches to study how behavioural, psychological, and social variables relate to DNA methylation.^[4][5] She was one of the first researchers to show that DNA could be a predictor of body weight: factors that influence the development of a baby in the womb (e.g. diet, smoking, stress) can predispose a child to obesity.^[6][7] Relton studied this using the Children of the 90s study.^[6] She used data from 520,000 people across Europe to demonstrate a link between levels of B vitamins and lung cancer, showing a reduced risk of lung cancer among people with high levels of Vitamin B6 and methionine.^[8]

Alongside her research position at Bristol, Relton is Pro-Director of Research and Development at the London School of Hygiene and Tropical Medicine.^[9]

• Gibran Hemani; Jie Zheng; Benjamin Elsworth; et al. (30 May 2018). "The MR-Base platform supports systematic causal inference across the human phenome". eLife. 7. doi:10.7554/ELIFE.34408. ISSN 2050-084X. PMC 5976434. PMID 29846171. Wikidata Q55427190.
• Bonnie R Joubert; Janine F Felix; Paul Yousefi; et al. (30 March 2016). "DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis". American Journal of Human Genetics. 98 (4): 680–696. doi:10.1016/J.AJHG.2016.02.019. ISSN 0002-9297. PMC 4833289. PMID 27040690. Wikidata Q36802570.
• Simone Wahl; Alexander Drong; Benjamin Lehne; et al. (21 December 2016). "Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity". Nature. 541 (7635): 81–86. doi:10.1038/NATURE20784. ISSN 1476-4687. PMC 5570525. PMID 28002404. Wikidata Q38779718.